Tiansheng Pharmaceutical Group

In 2001, Tiansheng Pharmaceutical was born in Chongqing, the youngest and most dynamic municipality in China. It is a modern medical technology enterprise and a national high-tech enterprise. In the past 16 years, Tiansheng Pharmaceutical has been adhering to the cultural concept of righteousness, learning, innovation and progress, and has worked hard to improve the company. The business scope covers pharmaceutical manufacturing, circulation, Chinese herbal medicine planting and processing, drug research and development, etc., forming a complete industrial chain. Three core strategies: Tiansheng is guided by the three major strategies. The boutique strategy always wins with quality, produces fine products, does not steal work, does not reduce materials, fulfills due diligence and perfects. Innovative strategy, constantly enriching and perfecting the product line and product structure layout, with Xiaoerfeike Granules, Yanshen Jianwei Capsule, Diqi Granule, Yinshen Tongluo Capsule, Yiqi Xiaoke Granule, Lingjing Capsule, etc. Represented more than 20 independent intellectual property rights, more than 300 commonly used varieties, 152 national medical insurance drugs, 77 national basic drugs, and continuously increased investment in research and development of new technologies and high value-added products. Currently, it has nearly 60 patents. A number of invention patents and core proprietary technologies are used in the manufacturing process of products, and the technical level is leading domestically. Talent-oriented strategy, attaches importance to the introduction and cultivation of talents, and guides the healthy, stable and orderly development of Tiansheng with integrity, standardization and solid operation.